Dr. Phillip Wade Paul, D.C. Chiropractor - Sports Physician Medicare: Accepting Medicare Assignments Practice Location: 224 E Main St, Royse City, TX 75189 Phone: 972-636-9008 |
Baker Spine And Sport Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 620 E Lamar St, Royse City, TX 75189 Phone: 972-635-9115 Fax: 972-635-9119 |
Royse City Chiropractic & Rehab Chiropractor Medicare: Medicare Enrolled Practice Location: 121 S Arch St, Royse City, TX 75189 Phone: 972-636-9008 |
Paul Chiropractic Pc Chiropractor - Sports Physician Medicare: Medicare Enrolled Practice Location: 224 E Main St, Royse City, TX 75189 Phone: 972-636-9008 |
Dr. Bradley Ray Baker, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 620 E Lamar St, Royse City, TX 75189 Phone: 972-635-9115 Fax: 972-635-9119 |
N8 Expressions Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 121 S Arch St, Royse City, TX 75189 Phone: 972-636-9008 Fax: 972-636-9739 |
Dr. Corina Mcclary Wild, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 309 Derick Dr, Royse City, TX 75189 Phone: -- |
News Archive
Sirius Genomics, a developer of companion diagnostics, announced today that it has signed its second Contribution Agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the first quarter ended March 31, 2010.
Research into how carbohydrates are converted into energy has led to a surprising discovery with implications for the treatment of a perplexing and potentially fatal neuromuscular disorder and possibly even cancer and heart disease.
An ambitious new study of genes in Asian populations is filling in big gaps in our understanding of human genetics, shedding light on the history of human migration and ultimately aiming to improve our ability to treat disease.
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.
› Verified 1 days ago